According to the sources provided, it is unclear whether or not discounts for Vascepa will still be available after its patent expiration. Vascepa is a prescription drug used to treat high levels of triglycerides in the blood. The drug's patent expired in 2020 [3], which means that other companies can now produce generic versions of the drug, which may result in lower prices [1]. However, the official Vascepa website offers a savings program for eligible patients [2]. It is not specified whether this program will continue after the patent expiration. It is also important to note that Amarin, the company that manufactures Vascepa, recently lost a patent appeal that would have protected the drug from generic competition until 2030 [3]. This ruling may impact the availability of discounts for Vascepa in the future. It is recommended that patients speak with their healthcare provider or pharmacist to learn more about available discounts for Vascepa.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://www.fiercepharma.com/marketing/it-s-confirmed-amarin-loses-patent-appeal-protecting-blockbuster-hopeful-vascepa-from